121 related articles for article (PubMed ID: 11189480)
1. [Clinical and genetic analysis of a severe vWD pedigree].
Yu L; Wang H; Du L
Zhonghua Xue Ye Xue Za Zhi; 1998 Sep; 19(9):451-4. PubMed ID: 11189480
[TBL] [Abstract][Full Text] [Related]
2. [Linkage analysis of vWD family by multi-PCR assay of microsatellite DNA in vWF gene].
Du L; Yu L; Wang H
Zhonghua Xue Ye Xue Za Zhi; 1998 Mar; 19(3):118-21. PubMed ID: 11243140
[TBL] [Abstract][Full Text] [Related]
3. Genetic linkage of two intragenic restriction fragment length polymorphisms with von Willebrand's disease type IIA. Evidence for a defect in the von Willebrand factor gene.
Verweij CL; Quadt R; Briët E; Dubbeldam K; van Ommen GB; Pannekoek H
J Clin Invest; 1988 Apr; 81(4):1116-21. PubMed ID: 2895123
[TBL] [Abstract][Full Text] [Related]
4. [Clinical application of linkage analysis for vWD family].
Zhou J; Yang Y; Jia YQ; Yang YM; Deng CQ; Jiang H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May; 35(3):391-4. PubMed ID: 15181846
[TBL] [Abstract][Full Text] [Related]
5. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
6. [Study on genetic mutations of the vWF in type 2A von Willebrand disease].
Wang Y; Zhang J; Zhang W; Cheng D; Wan H; Ruan C
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Aug; 17(4):229-32. PubMed ID: 10932002
[TBL] [Abstract][Full Text] [Related]
7. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.
Michiels JJ; Gadisseur A; Vangenegten I; Schroyens W; Berneman Z
Acta Haematol; 2009; 121(2-3):119-27. PubMed ID: 19506358
[TBL] [Abstract][Full Text] [Related]
8. Carrier detection in severe (type III) von Willebrand disease using two intragenic restriction fragment length polymorphisms.
Bahnak BR; Lavergne JM; Verweij CL; Rothschild C; Pannekoek H; Larrieu MJ; Meyer D
Thromb Haemost; 1988 Oct; 60(2):178-81. PubMed ID: 2905841
[TBL] [Abstract][Full Text] [Related]
9. A first Taiwanese Chinese family of type 2B von Willebrand disease with R1306W mutation.
Shen MC; Lin JS; Lin DS; Hsu SC; Lin B
Thromb Res; 2003; 112(5-6):291-5. PubMed ID: 15041272
[TBL] [Abstract][Full Text] [Related]
10. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
[TBL] [Abstract][Full Text] [Related]
11. Carrier detection in severe von Willebrand's disease.
Gupta PK; Kannan M; Saxena R
Ann Hematol; 2004 Oct; 83(10):625-7. PubMed ID: 15316757
[TBL] [Abstract][Full Text] [Related]
12. von Willebrand disease R1374C: type 2A or 2M? A challenge to the revised classification. High frequency in the northwest of Spain (Galicia).
Penas N; Pérez-Rodríguez A; Torea JH; Lourés E; Noya MS; López-Fernández MF; Batlle J
Am J Hematol; 2005 Nov; 80(3):188-96. PubMed ID: 16247740
[TBL] [Abstract][Full Text] [Related]
13. Laboratory diagnosis and molecular classification of von Willebrand disease.
Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
[TBL] [Abstract][Full Text] [Related]
14. New mutations in exon 28 of the von Willebrand factor gene detected in patients with different types of von Willebrand's disease.
Casaña P; Martínez F; Haya S; Tavares A; Aznar JA
Haematologica; 2001 Apr; 86(4):414-9. PubMed ID: 11325649
[TBL] [Abstract][Full Text] [Related]
15. Combined partial exon skipping and cryptic splice site activation as a new molecular mechanism for recessive type 1 von Willebrand disease.
Gallinaro L; Sartorello F; Pontara E; Cattini MG; Bertomoro A; Bartoloni L; Pagnan A; Casonato A
Thromb Haemost; 2006 Dec; 96(6):711-6. PubMed ID: 17139363
[TBL] [Abstract][Full Text] [Related]
16. Impact of 789Ala/Ala genotype on quantitative type of von Willebrand disease.
Ahmad F; Kannan M; Biswas A; Saxena R
Ann Hematol; 2009 May; 88(5):479-83. PubMed ID: 18923835
[TBL] [Abstract][Full Text] [Related]
17. Characterization of partial gene deletions in type III von Willebrand disease with alloantibody inhibitors.
Mancuso DJ; Tuley EA; Castillo R; de Bosch N; Mannucci PM; Sadler JE
Thromb Haemost; 1994 Aug; 72(2):180-5. PubMed ID: 7831648
[TBL] [Abstract][Full Text] [Related]
18. [Molecular study of type 2 von Willebrand disease].
Habart D; Smejkal P; Matýsková M; Turek P; Hrachovinová I; Vorlová Z
Cas Lek Cesk; 2003; 142(6):373-6. PubMed ID: 12924038
[TBL] [Abstract][Full Text] [Related]
19. [Mutation (Ala737-->Glu) in type 2A von Willebrand disease].
Wang Y; Zhang J; Wan H
Zhonghua Xue Ye Xue Za Zhi; 1999 Mar; 20(3):117-9. PubMed ID: 11601234
[TBL] [Abstract][Full Text] [Related]
20. Classification and characterization of hereditary types 2A, 2B, 2C, 2D, 2E, 2M, 2N, and 2U (unclassifiable) von Willebrand disease.
Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
Clin Appl Thromb Hemost; 2006 Oct; 12(4):397-420. PubMed ID: 17000885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
